BodeVet

BodeVet is a veterinary biotechnology company focused on developing shelf-stable blood products for the animal health market. The company utilizes a proprietary lyophilization technology to produce freeze-dried canine and equine plasma, marketed under the brand name StableP-L. These products are designed to provide immediate access to essential clotting factors and proteins in emergency and surgical settings without the need for specialized freezer storage. BodeVet's portfolio addresses critical conditions such as hemorrhage, coagulopathy, and hypoproteinemia in companion animals and horses. In 2020, the company was acquired by VCA Animal Hospitals, a division of Mars Veterinary Health, to enhance their specialty and emergency care offerings. The company continues to operate as a leader in veterinary transfusion medicine and regenerative therapies.